Access Now endo yasuko superior digital media. Pay-free subscription on our digital library. Dive in in a great variety of organized videos offered in top-notch resolution, great for high-quality watching lovers. With hot new media, you’ll always receive updates with the brand-new and sensational media aligned with your preferences. Reveal chosen streaming in breathtaking quality for a highly fascinating experience. Connect with our digital hub today to watch exclusive prime videos with for free, registration not required. Get access to new content all the time and discover a universe of singular artist creations designed for superior media aficionados. Seize the opportunity for original media—swiftly save now available to everybody at no cost! Continue exploring with immediate access and dive into top-tier exclusive content and commence streaming now! Experience the best of endo yasuko singular artist creations with dynamic picture and preferred content.

Mallinckrodt and endo are merging to create a leading global therapeutics company with branded and generic products Endo takes reports of alleged misconduct very seriously and will investigate them to determine if any law, company policy or aspect of our code of conduct may have been violated. Mallinckrodt and endo plan to combine their generic pharmaceuticals businesses and endo's sterile injectables business after the close of the transaction and intend to separate that business from the combined company at a later date.

Endo is providing the following financial guidance for the full year ending december 31, 2025 based on endo's current views, beliefs, estimates and assumptions. Mallinckrodt and endo have merged to create a global, scaled, diversified therapeutics leader Mallinckrodt and endo commenced mailing of the definitive joint proxy statement/prospectus to shareholders of mallinckrodt and endo, respectively, on or about may 12, 2025.

OPEN